# Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma

> **NCT04224831** · NA · COMPLETED · sponsor: **Ankara Universitesi Teknokent** · enrollment: 22 (actual)

## Conditions studied

- Central Serous Chorioretinopathy
- Chronic Central Serous Chorioretinopathy

## Interventions

- **COMBINATION_PRODUCT:** Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis

## Key facts

- **NCT ID:** NCT04224831
- **Lead sponsor:** Ankara Universitesi Teknokent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2019-09-30
- **Final completion:** 2020-01-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224831, "Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04224831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*